Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

203.82 -4.06 (-1.95%)

Streaming Delayed Price Updated: 3:03 PM EDT, Aug 31, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	872,600
Open	205.14
Bid (Size)	203.68 (200)
Ask (Size)	203.96 (100)
Prev. Close	207.88
Today's Range	200.53 - 206.30
52wk Range	37.88 - 224.31
Shares Outstanding	106,313,250
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer ↗

August 28, 2026

Revolution Medicines (NASDAQ:RVMD) said the U.S. Food and Drug Administration has approved daraxonrasib under the brand name RASONQUE for certain adults with metastatic pancreatic adenocarcinoma. The...

Via MarketBeat

Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X? ↗

August 28, 2026

The biotech's Rasonque is already available for prescription.

Via The Motley Fool

Performance

YTD	+157.9%	+157.9%
1 Month	+8.7%	+8.7%
3 Month	+24.5%	+24.5%
6 Month	+100.6%	+100.6%
1 Year	+415.6%	+415.6%

More News

Here's How Much $1000 Invested In Revolution Medicines 5 Years Ago Would Be Worth Today ↗

August 26, 2026

Via Benzinga

Revolution Medicines (NASDAQ:RVMD) Misses Q2 Estimates, Yet FDA Accepts Daraxonrasib Application ↗

August 05, 2026

Via Chartmill

Revolution Medicines (NASDAQ:RVMD) Flashes Strong Technical Breakout Setup ↗

July 30, 2026

Via Chartmill

Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't? ↗

August 25, 2026

Via The Motley Fool

GLP-1 Drugs Are Huge. These 2 Stocks Are Tapping Into an Even Bigger Opportunity ↗

August 24, 2026

Via The Motley Fool

Revolution Medicines (RVMD) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Via The Motley Fool

Meet the Vanguard ETF That's Crushing the S&P 500 and Nasdaq-100 Despite Not Owning Micron, Sandisk, or Any of the "Magnificent Seven" Stocks ↗

August 18, 2026

Via The Motley Fool

Here’s How Much You Would Have Made Owning Revolution Medicines Stock In The Last 5 Years ↗

August 07, 2026

Via Benzinga

Revolution Medicines Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy? ↗

August 03, 2026

Via The Motley Fool

Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock ↗

August 02, 2026

Via The Motley Fool

Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now ↗

July 29, 2026

Via The Motley Fool

This Stock Has Skyrocketed 125% in 2026 -- and Billionaire Stanley Druckenmiller Is Loading Up on It ↗

July 17, 2026

Via The Motley Fool

Better Growth Buy: Axsome vs Revolution Medicines ↗

July 09, 2026

Via The Motley Fool

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

July 07, 2026

From Revolution Medicines, Inc.

Via GlobeNewswire

These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More ↗

July 06, 2026

Via The Motley Fool

Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy? ↗

July 05, 2026

Via The Motley Fool

Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd. ↗

July 01, 2026

Via The Motley Fool

Can Revolution Medicines Be a Game-Changer Stock? ↗

June 11, 2026

Via The Motley Fool

Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock. ↗

June 05, 2026

Via The Motley Fool

Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion

June 03, 2026

Via Investor Brand Network

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation

June 03, 2026

Via Investor Brand Network

Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion

June 03, 2026

From BioMedWire

Via GlobeNewswire

Frequently Asked Questions

Is Revolution Medicines, Inc. - Common Stock publicly traded?

Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.

What exchange does Revolution Medicines, Inc. - Common Stock trade on?

Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?

The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market

What is the current price of Revolution Medicines, Inc. - Common Stock?

The current price of Revolution Medicines, Inc. - Common Stock is 203.82

When was Revolution Medicines, Inc. - Common Stock last traded?

The last trade of Revolution Medicines, Inc. - Common Stock was at 08/31/26 03:03 PM ET

What is the market capitalization of Revolution Medicines, Inc. - Common Stock?

The market capitalization of Revolution Medicines, Inc. - Common Stock is 21.67B

How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?

Revolution Medicines, Inc. - Common Stock has 22B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.